Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $39,966 | 1,995 | 95.7% |
| Travel and Lodging | $1,674 | 7 | 4.0% |
| Education | $127.34 | 5 | 0.3% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $16,574 | 640 | $0 (2024) |
| Boston Scientific Corporation | $4,473 | 248 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $2,917 | 177 | $0 (2024) |
| Vertos Medical, Inc. | $2,474 | 167 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,591 | 128 | $0 (2024) |
| Vertiflex, Inc. | $1,484 | 11 | $0 (2019) |
| SCILEX PHARMACEUTICALS INC. | $1,074 | 53 | $0 (2024) |
| Nevro Corp. | $875.79 | 27 | $0 (2023) |
| ABBVIE INC. | $805.90 | 35 | $0 (2024) |
| USWM, LLC | $733.69 | 28 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,206 | 189 | Abbott Laboratories ($922.27) |
| 2023 | $6,100 | 310 | Abbott Laboratories ($2,043) |
| 2022 | $7,761 | 353 | Abbott Laboratories ($3,263) |
| 2021 | $6,434 | 332 | Abbott Laboratories ($2,951) |
| 2020 | $4,449 | 250 | Abbott Laboratories ($2,203) |
| 2019 | $6,528 | 211 | Abbott Laboratories ($2,473) |
| 2018 | $3,308 | 189 | Abbott Laboratories ($1,580) |
| 2017 | $2,983 | 174 | Abbott Laboratories ($1,139) |
All Payment Transactions
2,008 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.49 | General |
| Category: Opioid Analgesic | ||||||
| 12/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Opioid Analgesic | ||||||
| 12/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Analgesic | ||||||
| 12/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $121.03 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: INSTRUMENTS | ||||||
| 11/26/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Analgesic | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Opioid Analgesic | ||||||
| 11/15/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Neuromodulation | ||||||
| 11/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2024 | Abbott Laboratories | SWIFT-LOCK (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $63.01 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/05/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 5,848 | 23,531 | $9.5M | $1.4M |
| 2022 | 33 | 5,023 | 17,483 | $8.2M | $1.2M |
| 2021 | 35 | 5,045 | 18,996 | $8.3M | $1.3M |
| 2020 | 30 | 4,442 | 15,425 | $3.7M | $812,253 |
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 977 | 4,095 | $2.7M | $423,768 | 15.9% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 128 | 168 | $966,000 | $133,469 | 13.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 265 | 1,009 | $580,175 | $112,618 | 19.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 451 | 1,771 | $531,300 | $107,540 | 20.2% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 187 | 413 | $413,000 | $99,345 | 24.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 269 | 371 | $522,034 | $81,665 | 15.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 230 | 1,549 | $318,010 | $80,348 | 25.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 193 | 367 | $286,260 | $56,320 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 260 | 260 | $289,601 | $46,536 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 360 | $165,559 | $26,539 | 16.0% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 26 | 85 | $1.0M | $22,408 | 2.2% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 69 | 96 | $136,810 | $21,260 | 15.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 81 | 310 | $103,540 | $15,948 | 15.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 981 | 3,933 | $104,814 | $15,634 | 14.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 44 | 71 | $123,923 | $15,552 | 12.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 90 | 117 | $164,631 | $9,732 | 5.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 15 | 23 | $62,000 | $9,634 | 15.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 53 | 85 | $51,311 | $8,503 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 57 | $51,705 | $8,222 | 15.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 14 | 36 | $37,110 | $7,960 | 21.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 42 | 68 | $60,496 | $7,596 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 66 | 94 | $61,297 | $7,533 | 12.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 29 | 32 | $44,465 | $6,995 | 15.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 63 | 106 | $38,486 | $6,055 | 15.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 41 | 80 | $36,904 | $6,028 | 16.3% |
About Dr. Patrick Fall, DO
Dr. Patrick Fall, DO is a Anesthesiology healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588638894.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Fall, DO has received a total of $41,768 in payments from pharmaceutical and medical device companies, with $4,206 received in 2024. These payments were reported across 2,008 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($39,966).
As a Medicare-enrolled provider, Fall has provided services to 20,358 Medicare beneficiaries, totaling 75,435 services with total Medicare billing of $4.8M. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Abington, PA
- Active Since 02/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1588638894
Products in Payments
- Proclaim Family of SCS IPGs (Device) $4,378
- PROCLAIM (Device) $4,165
- XTAMPZA (Drug) $2,644
- mild Device Kit (Device) $2,474
- WaveWriter Alpha Prime 16 (Device) $2,390
- Proclaim IPG (Device) $2,196
- Superion ISS (Device) $1,484
- RELISTOR (Drug) $1,393
- OCTRODE (Device) $908.89
- SCS IPGs (Device) $905.25
- Lucemyra (Drug) $885.47
- SPECTRA WAVEWRITER (Device) $843.57
- ETERNA (Device) $835.74
- Octrode SCS Leads (Device) $815.36
- ZTLido (Drug) $796.98
- UBRELVY (Drug) $469.94
- Omnia (Device) $444.18
- SCS leads (Device) $399.39
- MOVANTIK (Drug) $360.01
- SYMJEPI (Drug) $357.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Abington
Dr. Patrick Shum, M.d, M.D
Anesthesiology — Payments: $65.27
Denise Mann, M.d, M.D
Anesthesiology — Payments: $64.60
Patrick Breen, M.d, M.D
Anesthesiology — Payments: $36.90
Robert Koniuta, Md, MD
Anesthesiology — Payments: $34.45
Dr. Naheed Mohammed, M.d, M.D
Anesthesiology — Payments: $30.29
Geoffrey Kendall, Md, MD
Anesthesiology — Payments: $25.82